Hong Kong Stock Exchange · Healthcare
Invest in King International Investment stock from India
Indian and foreign residents can buy King International Investment (928) shares directly through Paasa.
By Paasa · Updated
King International Investment at a glance
- Price
- HK$0.12-HK$0.02 (11.59%)
- Market cap
- HK$225.75M
- Day range
- HK$0.10 – HK$0.13
- P/E
- 122.00
- Dividend yield
- None
- Volume
- 12.12M
- 1 month
- +16.19%
- 6 months
- +56.41%
- YTD
- +20.79%
- 1 year
- +10.91%
- 5 years
- +269.70%
King International Investment statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | HK$143.2M | HK$40.8M | HK$233.7M | HK$223.9M | HK$92.9M |
| Gross profit | HK$25.4M | HK$12.7M | HK$37.8M | HK$12.0M | HK$13.8M |
| Operating income | HK$9.1M | −HK$13.2M | HK$17.6M | −HK$32.5M | −HK$31.7M |
| Net income | HK$1.8M | −HK$47.5M | HK$15.8M | −HK$25.2M | −HK$34.5M |
| Earnings per share | HK$0.00 | −HK$0.03 | HK$0.01 | −HK$0.02 | −HK$0.03 |
| EBITDA | HK$9.6M | −HK$10.0M | HK$27.7M | −HK$26.7M | −HK$29.2M |
| Total assets | HK$385.2M | HK$286.4M | HK$336.1M | HK$264.3M | HK$302.9M |
| Total debt | HK$7.9M | HK$2.4M | HK$5.7M | HK$6.7M | HK$422.0K |
| Cash and short-term investments | HK$531.0K | HK$309.0K | HK$473.0K | HK$17.8M | HK$37.4M |
| Shareholders' equity | HK$238.2M | HK$222.6M | HK$269.8M | HK$237.5M | HK$262.3M |
| Operating cash flow | −HK$13.4M | −HK$322.0K | −HK$32.3M | −HK$134.5M | HK$96.9M |
| Free cash flow | −HK$13.4M | −HK$322.0K | −HK$32.3M | −HK$134.7M | HK$96.9M |
| Capital expenditure | HK$0.0 | HK$0.0 | HK$0.0 | −HK$214.0K | −HK$13.0K |
Fiscal years as reported, the latest ending 31 Mar 2026. Figures in HKD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Regent Pacific | 0575.HK | HK$0.82 | HK$239.29M |
| Extrawell Pharmaceutical | 0858.HK | HK$0.07 | HK$205.90M |
| PuraPharm | 1498.HK | HK$0.26 | HK$136.44M |
| Kelfred | 1134.HK | HK$0.23 | HK$115.00M |
| China Health | 8225.HK | HK$0.08 | HK$79.63M |
| China Regenerative Medicine International | 8158.HK | HK$0.26 | HK$77.58M |
| China Healthwise | 0348.HK | HK$0.07 | HK$56.25M |
| Elegance Optical International | 0907.HK | HK$0.06 | HK$53.24M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in King International Investment from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 928 and buy
Find King International Investment by name or by its ticker, 928, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in King International Investment from India
What King International Investment does
King International Investment Limited operates as a holding company, with its core activities focused on the provision of healthcare products and related services. The firm's business interests are diversified, also encompassing money lending and the distribution of alcoholic beverages. King International Investment operates in the Medical - Diagnostics & Research industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy King International Investment stock from India?
Yes. Indian residents and NRIs can buy King International Investment (928) shares directly through Paasa. King International Investment is listed on the Hong Kong Stock Exchange, in the Medical - Diagnostics & Research industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full King International Investment share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$0.12 a share, size the order by the lot, not by the share.
What tax do I pay in India when I sell King International Investment shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
Would my heirs owe estate tax on King International Investment shares?
Hong Kong has no estate duty. That is the source-country side; the shares themselves pass on like any other asset you hold in your own name.